ConductScience.org, home

Paper42420577

Co-targeting TWIST1 and JUNB suppresses CCL2-induced cell motility and hybrid EMT in ESCC models.

Ling Z and 5 others. Commun Biol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Co-targeting TWIST1 and JUNB suppresses CCL2-induced cell motility and hybrid EMT in ESCC models. Papers, record 42420577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42420577

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Co-targeting TWIST1 and JUNB suppresses CCL2-induced cell motility and hybrid EMT in ESCC models.
PubMed
Journal
Commun Biol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-06
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ling ZZihang
2Mu WWenxin
3Wang DDongyao
4Lv CChao
5Cheng BBinhttps://orcid.org/0000-0001-7288-806X
6Tao XXiaoanhttps://orcid.org/0000-0003-1114-9698

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Twist-Related Protein 1Major topic
Epithelial-Mesenchymal TransitionMajor topic
Chemokine CCL2Major topic
Cell MovementMajor topic
Nuclear ProteinsMajor topic
Transcription FactorsMajor topic
Esophageal Squamous Cell CarcinomaMajor topic
Esophageal NeoplasmsMajor topic
Animals
Humans
Cell Line, Tumor
Mice
Zebrafish
Signal Transduction
Gene Expression Regulation, Neoplastic

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82270975National Natural Science Foundation of China (National Science Foundation of China)PubMed
82401110National Natural Science Foundation of China (National Science Foundation of China)PubMed
202206080009Guangzhou Science and Technology Program key projectsPubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138342234Single-cell transcriptomic analysis reveals the landscape of epithelial-mesenchymal transition molecular heterogeneity in esophageal squamous cell carcinoma.Cancer Lett2024https://conductscience.org/library/papers/38342234PubMed
234809669TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34809669PubMed
333972779Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.Nat Genet2021https://conductscience.org/library/papers/33972779PubMed
438769475LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.Cell Mol Biol Lett2024https://conductscience.org/library/papers/38769475PubMed
534464477Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.Cell Prolif2021https://conductscience.org/library/papers/34464477PubMed
635177591Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma.Cell Death Dis2022https://conductscience.org/library/papers/35177591PubMed
736782089Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic Functions.Adv Sci (Weinh)2023https://conductscience.org/library/papers/36782089PubMed
833603224Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33603224PubMed
935791509Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.Cancer Commun (Lond)2022https://conductscience.org/library/papers/35791509PubMed
1039414946Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations.Nat Cancer2024https://conductscience.org/library/papers/39414946PubMed
1137005490Tumor microenvironment signaling and therapeutics in cancer progression.Cancer Commun (Lond)2023https://conductscience.org/library/papers/37005490PubMed
1237926835MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/37926835PubMed
1338503384Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy.Semin Cancer Biol2024https://conductscience.org/library/papers/38503384PubMed
1438457759Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial.J Clin Oncol2024https://conductscience.org/library/papers/38457759PubMed
1539334513Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma.Biomark Res2024https://conductscience.org/library/papers/39334513PubMed
1638572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1740105813Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma.JAMA Surg2025https://conductscience.org/library/papers/40105813PubMed
1827055731
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.
Lancet Oncol2016https://conductscience.org/library/papers/27055731PubMed
1938864342Identification and Characterization of Metastasis-Initiating Cells in ESCC in a Multi-Timepoint Pulmonary Metastasis Mouse Model.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38864342PubMed
2037259089EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?Mol Cancer2023https://conductscience.org/library/papers/37259089PubMed

See all 35 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42420577

GET https://conductscience.org/api/papers/v1/42420577/references?page=2